Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-457-1 | CAS number: 141-10-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Recent study according to OECD Guideline 415 under GLP, with full report and all individual data
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
- Reference Type:
- secondary source
- Title:
- No information
- Author:
- Beekhuizen MEW
- Year:
- 2 007
- Bibliographic source:
- OECD SIDS, Final 04/2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 415 [One-Generation Reproduction Toxicity Study (before 9 October 2017)]
- GLP compliance:
- yes
- Remarks:
- NOTOX BV
- Limit test:
- no
Test material
- Reference substance name:
- 6,10-dimethylundeca-3,5,9-trien-2-one
- EC Number:
- 205-457-1
- EC Name:
- 6,10-dimethylundeca-3,5,9-trien-2-one
- Cas Number:
- 141-10-6
- Molecular formula:
- C13H20O
- IUPAC Name:
- 6,10-dimethylundeca-3,5,9-trien-2-one
- Details on test material:
- - Name of test material (as cited in study report): Pseudoionone
- Manufacturer: Teranol AG, Lalden
- Lot/batch No.: UU02033826,
- Analytical purity: 95.4% (area, GC).
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Wistar Crl: (WI) BR (outbred, SPF quality)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Age at study initiation: males 5 - 6 weeks old; females 11 - 12 weeks old
- Identification: tattoo on the tail
- Housing: suspended stainless-steel cages, 4 animals per sex per cage, with males and females being kept in separate rooms. Mated females and males were housed individually in labelled polycarbonate cages containing sawdust (SAWI bedding, Jelu-Werk, Rosenberg, Germany) as bedding material. During the final stage of the pregnancy period, from day 16 post coitum, and during lactation, paper (Enviro-dri, BMI, Helmond, The Netherlands) was supplied to the dams for incorporation into the nest. The paper was replaced when soiled.
- Diet (e.g. ad libitum): ad libitum, standard pelleted rat diet (Altromin, code VRF1, Lage, Germany)
- Water (e.g. ad libitum): ad libitum, tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12
Analyses for all batches of feed and quarter-yearly analyses of tap water are retained at NOTOX archives
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- maize oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
- Pseudoionone was formulated daily
VEHICLE
- Amount of vehicle (if gavage): 5 ml/kg bw - Details on mating procedure:
- - M/F ratio per cage: 1/1 from same dose group
- Length of cohabitation: until vaginal plug was found; max. 3 weeks
- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy
- After 21 days of unsuccessful pairing pairs were separated.
- After successful mating each pregnant female was caged (how): individually - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Formulations were analytically confirmed to be stable for at least 4 hours at room temperature and to correspond to targeted concentrations.
- Duration of treatment / exposure:
- Exposure period: males: mean 106 (range 104-108) days;
females: mean 60 (range 36-65) days
Premating exposure period (males): 11 weeks
Premating exposure period (females): 2 weeks
Duration of test: 126 days - Frequency of treatment:
- once daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
40, 120 and 360 mg/kg bw/d
Basis:
nominal conc.
- No. of animals per sex per dose:
- 24
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: dose levels were based on a GLP 28-day subchronic toxicity study with the same dose levels that resulted in a NOEL of 50 mg/kg bw/d and a LOEL of 250 mg/kg bw/d with reversible effects (-> 7.5.1 Strobel1997.Repeated dose toxicity: oral rat 28d)
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: twice daily
BODY WEIGHT: Yes
- Time schedule for examinations: on the first day of exposure and weekly thereafter; Mated females were weighed on days 0, 7, 14 and 21 of gestation and during lactation on days 1, 4, 7, 14 and 21
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption of mated females was recorded on gestation days 0, 7, 14 and 21 and during lactation on days 1, 4, 7, 14 and 21
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes, but only subjective appraisal was maintained
REPRODUCTIVITY
- numbers of animals mated, mating date, confirmation of pregnancy and day of delivery were recorded - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight (1, 4, 7, 14 and 21 of lactation), physical or behavioural abnormalities - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals, males were killed after confirmation of the pregancy of the female they had been mated with or after successful delivery of the respective dam.
- Maternal animals: All surviving animals killed at day 21 post partum or shortly thereafter
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
-The tissues indicated were prepared for microscopic examination and weighed:
cervix plus uterus, epididymides (both together), kidney, liver, ovaries, pituitary (weighed after 24 h fixation), prostate (weighed after 24 h fixation), seminal vesicles together with coagulating gland and fluids, spleen and testes.
-All organ and tissue samples as listed below were processed, embedded, microtomed at 2-4 µm and stained with haematoxylin and eosin: kidneys and liver from 10 randomly selected animals per sex from all treatment groups. All slides were examined by a professional histopathologist, abnormalities were described and included in the histopathology report. The histopathologist was asked to add an interpretation of the findings - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring was sacrificed at at day 21 post partum.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows: Main offspring found dead or killed before day 14 of lactation were sexed and externally examined if practically possible. Main offspring found dead or killed on or after day 14 of lactation were sexed and subjected to external examination of the thoracic and abdominal tissues and organs
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
- All abnormalities were recorded. If possible, defects or cause of death were evaluated. - Statistics:
- For variables assumed to follow a normal distribution, the Dunnett test was applied; for other assumed distributions the Steel test was used. In those cases where variables could be dichotomised without loss of information, the exact Fisher test was applied. All tests were two-sided, significance was accepted at p < 0.05.
Results and discussion
Results: P0 (first parental generation)
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 120 mg/kg bw/day
- Sex:
- male/female
Results: F1 generation
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 360 mg/kg bw/day
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Protocol deviations
13 protocol deviations are listed in the report. All 13 were
evaluated and considered not to have affected the integrity
of the study or of the results.
Dose preparations
A first analysis of formulations prepared on 17-Jun-2002
showed values for accuracy within the range of 86-131% for
pseudoionone peak 1 and of 84-126% for peak 2, which was
considered insufficient. Additional analyses were performed
and the one of the formulations prepared on 24-Jun-2002
showed 98-102% for peak 1 and 97-102% for peak 2. The
insufficient results were considered to originate from
pipetting errors of the volatile solvent (n-hexane) during
sample pretreatment for chemical analysis. Preparations of
the formulations, however, were performed according to the
accurate method and it was concluded that the animals
received the complete and correct exposure to the test
substance.
Analyses for homogeneity of the low- and high-dose
formulations prepared on 17-Jun-2002, 24-Jul-2002 and
29-Aug-2002 all showed values within the range of 94-109%
for peak 1 and of 84-115% for peak 2, which were considered
acceptable for this type of formulations.
A stability analysis of the low- and high-dose formulations
from 17-Jun-2002 showed decreases over 7 days of 15% (peak
1) and and 11% (peak 2) for groups 40 mg/kg bd/d and of 15%
(peak 1) and 13% (peak 2) for group 360 mg/kg bw/d, which
was considered sufficient in view of the fact that
formulations were prepared daily.
Mortalities
There were 3 unscheduled deaths out of a total of 192 main
parental animals; all 3 animals were females. Two were
killed in extremis, one each in the 120 and the 360 mg/kg
bw/d groups after 38 respectively 43 days of treatment. The
other animal, also a female from the 360 mg/kg bw/d group,
died spontaneously on day 38. All three were found to have
severe delivery difficulties, with 17 foetuses in the birth
canal, 16 dead pups and three foetal resorptions, and 19
foetuses in the birth canal, respectively. These deaths were
considered incidental and very possibly caused by the big
litter sizes. Therefore, these deaths were considered not to
be related to the treatment with the test substance.
Clinical signs
Salivation was observed in all males and females of the
highest dose group. Incidental findings consisted of
alopecia, lethargy, clonic spasms, rales, salivation, scabs,
nodule at the tail, red staining of the right eye, broken
teeth, hunched posture, piloerection, pale appearance,
emaciation, dull eyes and dark eyes. No relationship was
established with treatment for these observations or they
were considered to be within the normal biological variation
for rats of this age and strain. Animal no. 40 of group 2
(40 mg/kg bw/d) showed several signs of stress (compulsive
biting, saltator spasms, tremor and muscle twitching) just
before or after dosing during four days of treatment.
Body weight
Body weights and body weight gain rates were unaffected by
treatment up to 360 mg/kg bw/d.
Food consumption
Statistically significant increases in relative food
consumption were observed in some of the 120 and 360 mg/kg
bw/d males. No explanation for this increase can be given,
however, this finding was not considered an adverse effect,
it was considered incidental in nature and not to be
toxicologically relevant.
Macroscopic examination
No treatment-related macroscopic findings were identified
but a number of findings that were considered incidental in
nature. These findings included pelvic dilation of the left,
right or both kidneys, testes reduced in size, flaccid
testes, enlarged testes, accentuated lobular pattern of the
liver, pale discolouration of the liver, alopecia at several
parts of the body, dark red discolouration of the
mediastinal cranial lymph nodes, isolated yellowish hard
nodule at the tail of the left epididymis, dark red hard
nodule at the left and right tips of the epididymides,
epididymides reduced in size, enlarged liver, reddish soft
nodule at the papillary process of the liver, soft nodule at
the papillary process of the liver, stomach and spleen grown
together with a soft nodule at the papillary process of the
liver, dark red discolouration of the left mandibular lymph
node. These findings are occasionally seen among rats used
in this type of study and, in the absence of correlated
microscopic histopathological findings, were not considered
of toxicological significance. Fluid in the uterus (in one
female of the control group, in three females of the 40
mg/kg bw/d group, in one female of the 120 group and in one
female of the 360 group) is related to a stage in the
oestrous cycle and is a normal finding.
In the 120 mg/kg bw/d group, one female that was killed in
extremis showed 17 foetuses in the birth canal. Of the 360
group, one female that was killed in extremis showed 3
foetal resorptions and 9 placentas in the left uterus horn
and the thoracic cavity containing milky-cloudy fluid; one
female from the 360 group that died spontaneously showed 19
foetuses in the birth canal and beginning autolysis.
Organ weights
Males and females of the 360 mg/kg bw/d group showed
statistically significant increased absolute and relative
liver and kidneys weight. Males of the 120 group showed
significantly increased liver weight:
----------------------------------------------------------
Dose group, Bodyweight-related organ weights (%bw),
mg/kg bw/d group mean values
-----------------------------------------
liver kidney
-------------------- --------------------
males females males females
----------------------------------------------------------
0 mean 3.33 4.28 0.68 0.69
SD 0.23 0.31 0.05 0.04
n 24 24 24 24
----------------------------------------------------------
40 mean 3.39 4.16 0.68 0.69
SD 0.19 0.45 0.06 0.05
n 24 22 24 22
----------------------------------------------------------
120 mean 3.61** 4.45 0.71 0.70
SD 0.20 0.25 0.07 0.05
n 24 23 24 23
----------------------------------------------------------
360 mean 4.13** 4.75** 0.77** 0.73*
SD 0.29 0.29 0.07 0.06
n 24 22 24 22
----------------------------------------------------------
*/**: Dunnett's test on pooled variance, significant at 5%
(*) or 1% (**) level.
----------------------------------------------------------
In the absence of histopathological changes, both effects
were considered not to be toxicologically relevant but
rather manifestations of physiological adaptation to
additional metabolic and excretionary loads.
Males of the 40 group showed statistically significantly
reduced seminal vesicles weight. In the absence of a
dose-response relationship, this finding was considered to
be caused by chance and not to be related to treatment.
Microscopic examination
There were no treatment-related findings. No
histopathological changes were found to correlate with the
observed increase in liver and kidney weights.
Reproduction
Reproduction parameters were unaffected by treatment up to
360 mg/kg bw/d. In the 40 group, one female did not mate and
one female was non-pregnant. In the 120 group, one female
showed delivery difficulties, and in the 360 group, two
females showed delivery difficulties. Mating performance,
duration of gestation and fertility parameters including
number of pups at birth were similar for the control and
treated groups.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.